POPS! Diabetes Care, Inc. (Equity)

Founding Year: 2016
Traction: POPS! Diabetes Care, Inc. has shown significant sales growth and is clinically proven to improve diabetes management. They have FDA clearance, TGA clearance, CE marking, and are in use across all 50 states and in Australia. POPS! has agreements with Best Buy, Zurich Insurance Group, and Medline.
Revenue Amount: $30,000,000
Organizations Involved: Mordor Intelligence, Center for Disease Control & Prevention
Founders: Lonny Stormo, Dan Davis, Curt Christensen
Company Description: POPS! Diabetes Care, Inc. has developed and commercialized a revolutionary AI self-care platform for diabetes management. Their mission is for people to take ownership of their diabetes through simple technology, with users in all 50 states and Australia. POPS! offers FDA Clearance, published clinical study outcomes, 100% client retention rate over three years, and a Net Promoter Score of 75. They have 15 issued and 7 pending patents, with a scalable software platform expanding into weight control, hypertension, and high cholesterol.
Market: Digital Health
Location: Minneapolis, MN, US
Coinvestors: None